Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
ASPE · NASDAQ · Pharmaceutical Preparations · No 10-K yet
Aspen Neuroscience (ASPE) · oqro.io/stocks/ASPE · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$12.59
Close of Nov 13, 2026 · end-of-day, not a live quote
49 routine filings (option exercises, shares withheld for taxes, grants, gifts) are not listed here. Show them
Insider buying
Traded Nov 2 · filed 2 days later
Since the trade −3.5% · S&P 500 +0.3% · to Nov 13
An Aspen Neuroscience director paid $15M out of pocket for Aspen Neuroscience shares. 3 other people at Aspen Neuroscience bought some too, in the same month. Shares held went up 39% with this purchase.
Insider buying
Traded Nov 2 · filed 2 days later
Since the trade −3.5% · S&P 500 +0.3% · to Nov 13
An Aspen Neuroscience director paid $15M out of pocket for Aspen Neuroscience shares. 3 other people at Aspen Neuroscience bought some too, in the same month. Shares held went up 39% with this purchase.
Insider buying
Traded Nov 2 · filed 1 day later
Since the trade −3.5% · S&P 500 +0.3% · to Nov 13
A major shareholder of Aspen Neuroscience paid $18M out of pocket for Aspen Neuroscience shares. 3 other people at Aspen Neuroscience bought some too, in the same month.
Traded Nov 2, 2026 · largest single transaction ~$18M
Nov 2, 2026~$18M · 1.2M sh @ $15.00
DetailsOfficial recordNov 2, 2026~$1M · 67K sh @ $15.00
DetailsOfficial recordNov 2, 2026~$1M · 67K sh @ $15.00
DetailsOfficial recordNo earnings release (8-K Item 2.02) is on file for ASPE, so its insider trades cannot be placed against one.